Author/Creator: Scaltriti, M. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Scaltriti, M.

1. Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy. (December 2016)

Authors:: Scaltriti, M.; Carmona, F.J.; Toska, E.; Cocco, E.; Hyman, D.; Cutler, R.; Avogadri-Connors, F.; Wick, M.J.; Papadopoulos, K.P.; Lalani, A.S.; Baselga, J.
Journal:: European journal of cancer
Issue:: Volume 69(2016)supplement 1
Page Start:: S125
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Tumor-infiltrating lymphocytes density correlates with HER2 gene copy number but not with protein levels in HER2-positive breast cancer. (April 2018)

Authors:: Fasani, R.; Comerma, L.; Pagliuca, F.; Thyparambil, S.; Peg, V.; Jimenez, J.; Cecchi, F.; Hembrough, T.; Perez, J.; Arribas, J.; Cortes, J.; Scaltriti, M.; Saura, C.; Nuciforo, P.
Journal:: European journal of cancer
Issue:: Volume 92(2018)Supplement 3
Page Start:: S128
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Tumor-specific PI3K inhibition by targeted delivery in head and neck squamous cell carcinoma. (December 2016)

Authors:: Mizrachi, A.; Shamay, Y.; Shah, J.K.; Brook, S.; Rajasekhar, V.K.; Humm, J.L.; Baselga, J.; Heller, D.A.; Haimovitz-Friedman, A.; Scaltriti, M.
Journal:: European journal of cancer
Issue:: Volume 69(2016)supplement 1
Page Start:: S66
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗